Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) FCF Margin: 2015-2020

Historic FCF Margin for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to 63,464.16%.

  • Outlook Therapeutics' FCF Margin rose 6355525.00% to 63,464.16% in Q3 2020 from the same period last year, while for Sep 2020 it was 1,809.88%, marking a year-over-year increase of 221164.00%. This contributed to the annual value of 2,179.11% for FY2024, which is 48139.00% up from last year.
  • Outlook Therapeutics' FCF Margin amounted to 63,464.16% in Q3 2020, which was up 4,627.44% from 1,342.46% recorded in Q2 2020.
  • In the past 5 years, Outlook Therapeutics' FCF Margin ranged from a high of 63,464.16% in Q3 2020 and a low of -3,332.90% during Q2 2016.
  • Moreover, its 3-year median value for FCF Margin was -974.82% (2018), whereas its average is 5,426.37%.
  • Per our database at Business Quant, Outlook Therapeutics' FCF Margin crashed by 228,840bps in 2016 and then skyrocketed by 6,355,525bps in 2020.
  • Over the past 5 years, Outlook Therapeutics' FCF Margin (Quarterly) stood at -1,975.99% in 2016, then surged by 71,335bps to -1,262.64% in 2017, then skyrocketed by 28,782bps to -974.82% in 2018, then skyrocketed by 209,145bps to 1,116.62% in 2019, then spiked by 6,355,525bps to 63,464.16% in 2020.
  • Its FCF Margin was 63,464.16% in Q3 2020, compared to 1,342.46% in Q2 2020 and 1,017.46% in Q1 2020.